Careers in Technology Transfer

Ever since the Bayh-Dole Act of 1980, which allows universities, federally funded research labs, and small businesses to own and patent inventions discovered in federally funded research programs, the profession of commercializing research has been growing and changing. Technology transfer managers help shepherd an idea conceived by scientists in academia or government research centers to commercialization in the private sector. They deal with evaluating discoveries for commercial potential, pat

Written byKaren Young Kreeger
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Ever since the Bayh-Dole Act of 1980, which allows universities, federally funded research labs, and small businesses to own and patent inventions discovered in federally funded research programs, the profession of commercializing research has been growing and changing. Technology transfer managers help shepherd an idea conceived by scientists in academia or government research centers to commercialization in the private sector. They deal with evaluating discoveries for commercial potential, patenting and licensing commercial rights, and brokering deals with potential investors. Professionals in this area are employed at universities, medical centers, federal research labs, and in industry.

The job market right now for scientists or anyone with the right experience and credentials to enter technology transfer is "terrific," says James Severson, president of the Association of University Technology Managers (AUTM) and president of the Cornell Research Foundation, the technology transfer unit for Cornell University in Ithaca, N.Y. "I think this reflects the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies